Skip to main content

Altimmune, Inc.

ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001326190

In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in Altimmune, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
103
+1 vs. Q4 2021
Shares held
33.7M
+1.18M (+3.6%) vs. Q4 2021
Total value
$207.4M
−$88.4M (−29.9%) vs. Q4 2021
New holders
20
35 more added
Sold out
19
31 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 103 institutions
Q1 2021: 98 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 102 institutionsQ1 2022: 103 institutionsQ2 2022: 111 institutionsQ3 2022: 122 institutionsQ4 2022: 128 institutionsQ1 2023: 133 institutionsQ2 2023: 120 institutionsQ3 2023: 113 institutionsQ4 2023: 143 institutionsQ1 2024: 171 institutionsQ2 2024: 173 institutionsQ3 2024: 169 institutionsQ4 2024: 183 institutionsQ1 2025: 177 institutionsQ2 2025: 180 institutionsQ3 2025: 159 institutionsQ4 2025: 183 institutionsQ1 2026: 173 institutionsQ2 2026: 210 institutions
Value heldQ1 2022: $207.4M
Q1 2021: $336.5MQ2 2021: $269.2MQ3 2021: $375.3MQ4 2021: $295.8MQ1 2022: $207.4MQ2 2022: $466.9MQ3 2022: $588.1MQ4 2022: $769.9MQ1 2023: $205.4MQ2 2023: $124.5MQ3 2023: $79.2MQ4 2023: $377.1MQ1 2024: $452.2MQ2 2024: $282.1MQ3 2024: $243.0MQ4 2024: $292.3MQ1 2025: $191.2MQ2 2025: $145.5MQ3 2025: $156.4MQ4 2025: $198.8MQ1 2026: $213.5MQ2 2026: $456.1M
Institutions holding ALT and their total value by quarter
QuarterHoldersValue
Q2 2026210$456.1M
Q1 2026173$213.5M
Q4 2025183$198.8M
Q3 2025159$156.4M
Q2 2025180$145.5M
Q1 2025177$191.2M
Q4 2024183$292.3M
Q3 2024169$243.0M
Q2 2024173$282.1M
Q1 2024171$452.2M
Q4 2023143$377.1M
Q3 2023113$79.2M
Q2 2023120$124.5M
Q1 2023133$205.4M
Q4 2022128$769.9M
Q3 2022122$588.1M
Q2 2022111$466.9M
Q1 2022103$207.4M
Q4 2021102$295.8M
Q3 2021119$375.3M
Q2 2021109$269.2M
Q1 202198$336.5M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Altimmune, Inc.; share changes are against Q4 2021.

Institutions holding ALT in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Avidity Partners Management LP2,865,000$17.4M0.39%+100,000+3.6%Added
BlackRock Inc.2,936,324$17.9M0.00%−19,943−0.7%Reduced
Nuveen Asset Management, LLC3,245,204$22.2M0.01%+949,372+41.4%Added
Rafferty Asset Management, LLC0$00.00%−362,943−100.0%Sold out
PointState Capital LP0$00.00%−135,000−100.0%Sold out
Walleye Trading LLC0$00.00%−49,083−100.0%Sold out
NinePointTwo Capital0$00.00%−37,168−100.0%Sold out
National Asset Management, Inc.0$00.00%−34,000−100.0%Sold out
Wolverine Trading, LLC0$00.00%−33,555−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−27,000−100.0%Sold out
Parametric Portfolio Associates LLC0$00.00%−21,832−100.0%Sold out
LMR Partners LLP0$00.00%−20,000−100.0%Sold out
Caption Management, LLC0$00.00%−15,519−100.0%Sold out
SG Americas Securities, LLC0$00.00%−13,565−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−11,936−100.0%Sold out
Cutler Group LP0$00.00%−900−100.0%Sold out
CWM, LLC0$00.00%−775−100.0%Sold out
Godsey & Gibb Associates0$00.00%−611−100.0%Sold out
Carroll Investors, Inc0$00.00%−272−100.0%Sold out
State of Wyoming0$00.00%−58−100.0%Sold out
Cornerstone Advisory, LLC0$00.00%−32−100.0%Sold out
BCR Wealth Strategies, LLC0$00.00%−4−100.0%Sold out